Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

50 results
Display

Effect of Lovastatin on Serum Lipids in Primary Hypercholesterolemia

Park WH, Kim SW, Woo EJ, Kang SW, Hwang JY, Chae SC, Jun JE

10 Patients with primary hypercholesterolemia were treated for 12 weeks with lovastation(20mg t.i.d). Lovastatin reduced mean total and low density lipoprotein cholesterol by 43% and 57% respectively(p
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Lovastatin in Combination with 5-FU on Stomach Cancer Cells

Park C, Kang WK

  • KMID: 2059145
  • J Korean Cancer Assoc.
  • 1997 Oct;29(5):785-790.
No abstract available
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Lovastatin(Mevacor(R)) in Patients with Hypercholesterolemia

Lee SY, Kyoung CS, Kim DC, Lee KH, Choi SJ, Son I, Park SH

Lovastatin is a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, which catalyzes the conversion of hydroxymethylglutaryl-coenzyme A to mevalonate, anearly and rate-limiting step in the synthesis of cholesterol. We studied...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effects of lovastatin on puromycin aminonucleoside-induced focal segmental glomerulosclerosis in rats

Kim MJ, Choi IJ

  • KMID: 1694942
  • Korean J Nephrol.
  • 1991 Dec;10(4):492-504.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of lovastatin on serum lipids of patients with primary hypercholesterolemia

Kim KS, Kim JH, Lim HK, Lee BH, Lee JK

  • KMID: 1691757
  • Korean J Crit Care Med.
  • 1993 Jun;8(1):7-11.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Lovastatin(Mevacor(R)) on Lowering Plasma Lipids in Patients with Hyperlipidemia

Lee HJ, Min CH, Choi KS, Ryu WS, Ryoo UH

Lovastatin, a competitive inhibitor of the rate limiting enzyme in cholesterol biosynthesis was administered to 34 patients with primary hypertlipidemia, 20 mg once daily with the evening meal. Patients experienced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ichthysiform Skin Eruptions Possibly Due to Lovastatin(Mevacor)

Park JH, Oh KS, Lee HJ, Whang KU

  • KMID: 2303407
  • Korean J Dermatol.
  • 1999 Apr;37(4):535-537.
Lovastatin(Mevacor) belongs to a new generation of potent drugs for the treatment of hypercho- lesterolemia. It acts by competitive inhibition of 3-hydroxyl-3-methylglutaryl coenzyme A(HMG-CoA) reductase, diminishing in that way the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiproliferative Effect of Lovastatin on Vascular Smooth Muscle Cell

Park SW, Kim DK, Huh JE, Choi YH, Choi YH, Gwon HC, Kim JS, Lee SH, Hong KP, Park JE, Seo JD, Lee WR

BACKGROUND AND OBJECTIVES: This study was performed to investigate the antiproliferative effect of lovastatin on vascular smooth muscle cell, especially to determine whether lovastatin induces apoptosis in vascular smooth muscle...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Preventive Effects of Bcl-2 and Bcl-xL on Lovastatin-induced Apoptosis of C6 Glial Cells

Choi JW, Lee JM, Oh YJ

  • KMID: 2285257
  • Korean J Physiol Pharmacol.
  • 2002 Oct;6(5):235-240.
It has been reported that lovastatin induced cell death and suppressed proliferation in various cell lines. In this study, we examined whether the cytotoxic effects of lovastatin could be prevented...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Lovastatin(Mevacor(R)) on Serum Lipids of Patients with Hypercholesterolemia

Lee WK, Yoon J, Jang YS, Cho SY, Shim WH, Kim SS, Chung N

We evaluated the hypolipidemic effect and adverse reaction of Lovastatin, HMG-CoA reductase inhibitor 20 to 40mg once-daily in the evening, in 20 patients with primary hypercholesterolemia for 12 weeks and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Lovastatin(Mevacor(R)) on Serum Lipid of Patient with Noninsulin Dependent Diabetes Mellitus

Shin GJ, Kyung NH

Patient with noninsulin dependent diabetes mellitus(NIDDM) have a major risk factor of the coronary herat disease which is important cause of death in NIDDM patients. In addition, they have relatively...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Three Cases of Lovastatin Induced Rhabdomyolysis Following Renal Transplantation

Kim YH, Kim HJ, Lee G, Choi CW, Lee TW, Ihm CG, Kim MJ

  • KMID: 2198988
  • J Korean Soc Transplant.
  • 2001 Dec;15(2):246-250.
In renal transplantation, cardiovascular disease is a frequent cause of mortality and morbidity. Post-transplant lipoprotein abnormalities may contribute to the development of cardiovascular disease and chronic renal allograft rejection. Post-...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypolipidemic Effects and Safety of Lovastatin in Patients with Primary Hypercholesterolemia

Bae JH, Choue CW, Kim KS, Kim MS, Song JS

To evaluate the efficacy and safety of lovastatin, new hypolipidemic agent of HMG-CoA reductase inhibitor, we administered lovastatin 40mg to 80mg once daily for 12 weeks in 20 patients(7 males,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Acquired Ichthyosis Developed During Cholesterol-lowering Treatment

Jeong SJ, Kim YT

  • KMID: 2303472
  • Korean J Dermatol.
  • 1997 Jun;35(3):546-550.
A 42-year-old woman presented with ichthyosiform eruptions on her trunk and buttock which developed 20 days prior to consulatation. She had taken the cholesterol-lowering drug(lovastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genome Shuffling of Mangrove Endophytic Aspergillus luchuensis MERV10 for Improving the Cholesterol-Lowering Agent Lovastatin under Solid State Fermentation

El-Gendy M, Al-Zahrani HAA, El-Bondkly AMA

In the screening of marine mangrove derived fungi for lovastatin productivity, endophytic Aspergillus luchuensis MERV10 exhibited the highest lovastatin productivity (9.5 mg/gds) in solid state fermentation (SSF) using rice bran....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Lovastatin(Mevacor(R)) on Serum Lipids of Patients with Primary Hyperlipidemia

Yoo WS, Lee SB, Ahn JH, Kim K, Lee DC, Rhee KJ, Choi SK

A new hypolipidemic agent, lovastatin, hydroxy-methyl-gultaryl coenzyme A reductase inhibitor was administred to 25 patients with primary hyperlipidemia 20 to 40 mg daily for 12 weeks and sequential changes of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiatherogenic Effect of Naringin Independent of Lipid-Lowering Action in Hypercholesterolemic Rabbits

Choe SC, Kim HS, Jeong TS, Bok SH, Park YB

BACKGROUND: Naringin, one of the flavonoids in citrus fruit peels, is known to have antioxidant and hepatotonic effects in animal studies. We evaluated the effect of naringin on 1) blood...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Efficacy of Lovastatin in Patients with Hypercholesterolemia

Kim JS, Chai IH, Park SW, Hong SK, Kim HS, Kim CH, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW

BACKGROUND: This study was designed to evaluate the clinical efficasy of lovastatin, HMG-CoA reductase inhibitor, in patients with hypercholesterolemia. METHODS AND RESULTS: Lovastatin 20 to 80 mg were administered once daily...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Lovastatin on Free Fatty Acid Oxidation in Cultured L6 Rat Skeletal Muscle Cells

Kim DL, Song KH, Kim HR, Kim SK

BACKGROUND: Recent clinical studies suggest that statins improve insulin resistance and glucose metabolism in patients with metabolic syndrome and type 2 diabetes. To evaluate the possible mechanism of this action,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells

Choi KH, Kang SW, Lee SW, Lee HY, Han DS, Kang BS

In order to investigate the anti-proliferative effect of 3-hydroxy-3-methylglutaryl coenzyme. A reductase inhibitor, we evaluated the effects of lovastatin on DNA replication and the proliferation of rat mesangial and aortic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr